Sysmex Corporation (SSMXF)
OTCMKTS · Delayed Price · Currency is USD
15.80
+0.50 (3.27%)
Jul 25, 2025, 4:00 PM EDT
Sysmex Market Cap
Sysmex has a market cap or net worth of $10.54 billion as of July 29, 2025. Its market cap has increased by 8.85% in one year.
Market Cap
10.54B
Enterprise Value
10.38B
Revenue
3.40B
Ranking
n/a
PE Ratio
29.42
Stock Price
$15.80
Market Cap Chart
Since September 5, 1996, Sysmex's market cap has increased from 479.17M to 10.54B, an increase of 2,100.33%. That is a compound annual growth rate of 11.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2025 | 10.54B | -8.88% |
| Dec 30, 2024 | 11.57B | -0.83% |
| Dec 29, 2023 | 11.67B | -8.05% |
| Dec 30, 2022 | 12.69B | -55.08% |
| Dec 30, 2021 | 28.25B | 12.64% |
| Dec 30, 2020 | 25.08B | 75.55% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.81B |
| Veradigm | 789.71M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 590.95M |
| Glass House Brands | 435.80M |
| Northwest Biotherapeutics | 379.00M |
| CytoDyn | 371.09M |